Skip to main content
Top

22-04-2024 | Rubella | Letter to the Editor

Rubella virus-associated cutaneous granulomatous disease in an immunocompetent woman

Authors: Vega-López TL, Carballido-Vázquez AM, González-Jiménez I, García-Gamero MJ, Delgado-Mucientes CM, González-López A, Martínez-García G, Rojo-Rello S, Manchado-López P, Mateos-Mayo A

Published in: European Journal of Clinical Microbiology & Infectious Diseases

Login to get access

Excerpt

Cutaneous granulomatous diseases encompass the clinical spectrum of type-IV hypersensitivity reactions, leading to granuloma formation. Histologically, granulomas represent a chronic inflammatory response characterized by focal aggregates of epithelioid histiocytes, multinucleated giant cells, and mononuclear leukocytes. Although their etiology frequently remains unclear, granulomas normally develop in response to chronic infection [1]. Interestingly, the term “rubella virus (RuV) granulomas” has recently been introduced to describe granulomas in which vaccine-derived or wild-type RuV (wt-RuV) has been identified in tissue biopsy [2]. …
Literature
Metadata
Title
Rubella virus-associated cutaneous granulomatous disease in an immunocompetent woman
Authors
Vega-López TL
Carballido-Vázquez AM
González-Jiménez I
García-Gamero MJ
Delgado-Mucientes CM
González-López A
Martínez-García G
Rojo-Rello S
Manchado-López P
Mateos-Mayo A
Publication date
22-04-2024
Publisher
Springer Berlin Heidelberg
Keyword
Rubella
Published in
European Journal of Clinical Microbiology & Infectious Diseases
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-024-04828-5
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.